Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Arnd Voerste"'
Autor:
Arnd Voerste, Ho-Wai Chan, Man-Ki Cheung, Shuk Ting Chung, Wai-Lun Lam, Richard K. Haynes, Ian D. Williams, Hing-Wo Tsang
Publikováno v:
European Journal of Organic Chemistry. 2003:2098-2114
Lewis acid-catalysed arylation of the 10β-benzoate and, less effectively, the 10α-benzoate of dihydroartemisinin [DHA] with activated aromatic compounds, including naphthalenes, stereoselectively, provides 10α-aryl derivatives including disubstitu
Autor:
Wai-Lun Lam, Arnd Voerste, Ho-Wai Chan, Man-Ki Cheung, May-Kei Soo, Hing-Wo Tsang, Ian D. Williams, Richard K. Haynes
Publikováno v:
European Journal of Organic Chemistry. 2002:113-132
Preparative and stereochemical aspects of reactions providing new C-10 ester and ether derivatives of the antimalarial drug dihydroartemisinin (DHA, 2) have been examined. β-Artesunate has been prepared for the first time, and has been differentiate
Publikováno v:
Tetrahedron Letters. 40:4715-4718
In CH 2 Cl 2 in the presence of benzylamine, artemisinin transfers an oxygen atom from the intermediate open hydroperoxide to tertiary amines to form N -oxides and N -benzyl-11-azadesoxyarte-misinin. Base-catalyzed side reactions interfere with the c
Publikováno v:
ChemInform. 30
In CH 2 Cl 2 in the presence of benzylamine, artemisinin transfers an oxygen atom from the intermediate open hydroperoxide to tertiary amines to form N -oxides and N -benzyl-11-azadesoxyarte-misinin. Base-catalyzed side reactions interfere with the c
Autor:
Frank Mauler, Laurent Prézeau, Andreas Stolle, Arnd Voerste, Thomas Müller, Philip M Beart, Cécile Joly, Isabelle Brabet, Joël Bockaert, Fiona Y Carroll, Jean-Philippe Pin, Horst Antonicek
Publikováno v:
Molecular Pharmacology
Molecular Pharmacology, American Society for Pharmacology and Experimental Therapeutics, 2001, 59 (5), pp.965-73. ⟨10.1124/mol.59.5.965⟩
Molecular Pharmacology, 2001, 59 (5), pp.965-73. ⟨10.1124/mol.59.5.965⟩
Molecular Pharmacology, American Society for Pharmacology and Experimental Therapeutics, 2001, 59 (5), pp.965-73. ⟨10.1124/mol.59.5.965⟩
Molecular Pharmacology, 2001, 59 (5), pp.965-73. ⟨10.1124/mol.59.5.965⟩
Lien vers le texte intégral de l'éditeur http://molpharm.aspetjournals.org/cgi/reprint/59/5/965; International audience; L-Glutamate (Glu) activates at least eight different G protein-coupled receptors known as metabotropic glutamate (mGlu) recepto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fe398e4b5100a6d026337e616d258f3
https://www.hal.inserm.fr/inserm-00319007/file/Carroll-BAY367620-MolPharmacol.pdf
https://www.hal.inserm.fr/inserm-00319007/file/Carroll-BAY367620-MolPharmacol.pdf
Publikováno v:
European journal of pharmacology. 388(2)
LY354740 ¿(1S,2S,5R,6S)-2-aminobicyclo[3.1.0]hexane-2, 6-dicarboxylate monohydrate¿, a selective group II metabotropic glutamate (mGlu) receptor agonist, was recently reported to attenuate the behavioral effects of phencyclidine (PCP) in rats. In t
Autor:
Richard K. Haynes, Ho-Wai Chan, Man-Ki Cheung, Shuk Ting Chung, Wai-Lun Lam, Hing-Wo Tsang, Arnd Voerste, Ian D. Williams
Publikováno v:
European Journal of Organic Chemistry; Jun2003, Vol. 2003 Issue 11, p2098-2114, 17p